Deprescriptions
11
1
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Effects of Communication Training to Involve Older People in Decisions to DEPRESCRIBE Cardiometabolic Medication: a Cluster-randomized Trial in Primary Care
Prescribing Outcomes of a GP-Targeted Deprescribing Educational Intervention: A Cluster Randomized Trial
Optimising Medication With Focus on Deprescribing in Frail Older People With Multidose Drug Dispensing Systems
Standardized Patient-Centered Medication Review in Home Hospice
Engaging Patients to Promote Deprescribing
Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults
Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
A Clinical Decision Support System and Patient Portal for Preventing Medication-related Falls in Older Patients
Optimization of Deprescribing Antidepressants in Nursing Home Residents With Dementia
Effectiveness of a Person-centred Prescription Model at the End of Life
Deprescribing: a Portrait and Out-comes of the Reduction of Polypharmacy in Portugal